loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 76925 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 PADAGIS US (1)

filter

01 SUSPENSION;ORAL (1)

filter

01 RX (1)

filter

01 IBUPROFEN (1)

filter

01 No (1)

URL Supplier Web Content
SUSPENSION; ORAL
100MG/5ML
2004-09-23
76925
IBUPROFEN
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 76925

Looking for FDA Orange Book APPLICATION 76925 1

19

Padagis, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA.

They are recognized for Setting a smart pace for the extended Topicals Rx marketplace.

One of their notable products is IBUPROFEN, with a corresponding application number 76925.

Regulatory Information RX

With a dosage strength 100MG/5ML

Dosage Form Route SUSPENSION; ORAL

Reference Listed Drug No

Approved since 2004-09-23

Therapeutic Equivalence (TE) Code AB

Post Enquiry
POST ENQUIRY